CLDN4 and neoplasm: As expected, we observed a tumor cluster with markers (TACSTD2, LYPD3, LY6D, CLDN4, KRT6A, KRTDAP) characteristic of previously reported basal to squamous carcinoma transition (BST) phenotype17,18.